Effects of water-insoluble wheat bran-fraction powder on disease activity and caecal microbiota in dextran sodium sulphate-induced inflammatory bowel disease mouse model.
Allobaculum
Faecalibaculum
Gut microbiota
Insoluble fibres
Intestinal bowel disease
Wheat bran
Journal
Molecular biology reports
ISSN: 1573-4978
Titre abrégé: Mol Biol Rep
Pays: Netherlands
ID NLM: 0403234
Informations de publication
Date de publication:
01 Nov 2024
01 Nov 2024
Historique:
received:
19
09
2024
accepted:
21
10
2024
medline:
1
11
2024
pubmed:
1
11
2024
entrez:
1
11
2024
Statut:
epublish
Résumé
Water-soluble arabinoxylan exerts anti-colitic effect and exhibits ameliorative activity in an inflammatory bowel disease (IBD) mouse model. Water soluble fibre from wheat bran (WB) also exhibits anti-colitic effect. However, arabinoxylan is a primary compound of insoluble polysaccharide (hemicellulose) in WB. This study aimed to clarify the anti-IBD effects of the WB water-soluble (WBS) and water-insoluble (WBI) fractions. WB suspension was autoclaved and fractionated to WBS and WBI. C57BL/6 mice were divided into control (CT), dextran sodium sulphate (DSS), WBI, and WBS groups. They were fed as follows from day 1: CT, standard diet and distilled water; DSS and WBI, 3% (w/v) DSS in drinking water; WBI, 8% (w/w) WBI diet; and WBS, 50% (v/v) WBS and 3% (w/v) DSS in water. DSS group mice showed diarrhoea, body weight reduction, and blood in faeces by day 5 and colon tissue damage by day 6. These inflammatory indices were significantly inhibited by treatment with WBI. Amplicon sequencing of the 16S rDNA (V4) gene of the caecal contents of the CT, DSS, and WBI groups showed that the abundances of Escherichia, Allobaculum, and Bacteroidaceae increased and that of Faecalibaculum decreased in the DSS group. KEGG pathway prediction showed that amino acid metabolism and lipopolysaccharide biosynthesis decreased and increased, respectively, in the DSS group. However, WBI treatment tended to suppress these effects. WBI, rather than WBS, reduces inflammation and maintains the gut microbiota. However, further studies are warranted to elucidate the properties of the WBI active components and efficacy of WBI metabolites on gut microbiota, particularly on Faecalibaculum.
Sections du résumé
BACKGROUND
BACKGROUND
Water-soluble arabinoxylan exerts anti-colitic effect and exhibits ameliorative activity in an inflammatory bowel disease (IBD) mouse model. Water soluble fibre from wheat bran (WB) also exhibits anti-colitic effect. However, arabinoxylan is a primary compound of insoluble polysaccharide (hemicellulose) in WB. This study aimed to clarify the anti-IBD effects of the WB water-soluble (WBS) and water-insoluble (WBI) fractions.
METHODS AND RESULTS
RESULTS
WB suspension was autoclaved and fractionated to WBS and WBI. C57BL/6 mice were divided into control (CT), dextran sodium sulphate (DSS), WBI, and WBS groups. They were fed as follows from day 1: CT, standard diet and distilled water; DSS and WBI, 3% (w/v) DSS in drinking water; WBI, 8% (w/w) WBI diet; and WBS, 50% (v/v) WBS and 3% (w/v) DSS in water. DSS group mice showed diarrhoea, body weight reduction, and blood in faeces by day 5 and colon tissue damage by day 6. These inflammatory indices were significantly inhibited by treatment with WBI. Amplicon sequencing of the 16S rDNA (V4) gene of the caecal contents of the CT, DSS, and WBI groups showed that the abundances of Escherichia, Allobaculum, and Bacteroidaceae increased and that of Faecalibaculum decreased in the DSS group. KEGG pathway prediction showed that amino acid metabolism and lipopolysaccharide biosynthesis decreased and increased, respectively, in the DSS group. However, WBI treatment tended to suppress these effects.
CONCLUSION
CONCLUSIONS
WBI, rather than WBS, reduces inflammation and maintains the gut microbiota. However, further studies are warranted to elucidate the properties of the WBI active components and efficacy of WBI metabolites on gut microbiota, particularly on Faecalibaculum.
Identifiants
pubmed: 39485667
doi: 10.1007/s11033-024-10045-2
pii: 10.1007/s11033-024-10045-2
doi:
Substances chimiques
Dietary Fiber
0
Dextran Sulfate
9042-14-2
Powders
0
arabinoxylan
9040-27-1
Water
059QF0KO0R
Xylans
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1112Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Vicentin L, Canales J, Calderini DF (2024) The trade-off between grain weight and grain number in wheat is explained by the overlapping of the key phases determining these major yield components. Fron Plant Sci 15:1380429
doi: 10.3389/fpls.2024.1380429
Rossi D, Rossi S, Cinelli P, Seggiani M (2024) Emerging opportunities in the valorisation of wheat bran byproduct as additive in polymer composite materials. Mater Today Sustain 27:100832
Mao Y, Zhang Y, Li T, Chen Y, Wang Z, Guo C, Jin W, Shen W, Li J (2024) Effects of airflow superfine pulverization on the structure, functional properties, and flavor quality of wheat bran. J Sci Food Agric 104:8655–8669
Chen Z, Mense AL, Brewer LR, Shi Y-C (2024) Wheat bran arabinoxylans: Chemical structure, extraction, properties, health benefits, and uses in foods. Compr Res Food Saf 23:e13366
doi: 10.1111/1541-4337.13366
Yadav MP, Kaur A, Singh B, Simon S, Kaur N, Powell M, Sarker M (2021) Extraction and characterization of lipids and phenolic compounds from the brans of different wheat varieties. Food Hydroco 117:106734
doi: 10.1016/j.foodhyd.2021.106734
Ross PA, Xu W, Jalomo-Khayrova E, Bange G, Gumerov VM, Bradley PH, Sourjik V, Zhulin IB (2024) Framework for exploring the sensory repertoire of the human gut microbiota. mBio 15:e01039–e01024
doi: 10.1128/mbio.01039-24
pubmed: 38757952
pmcid: 11237719
Salvadori M, Rosso G (2024) Update on the gut microbiome in health and diseases. World J Methodol 14:89196
doi: 10.5662/wjm.v14.i1.89196
pubmed: 38577200
pmcid: 10989414
Ross FC, Patangia D, Grimaud G, Lavelle A, Dempsey EM, Ross RP, Stanton C (2024) The interplay between diet and the gut microbiome: implications for health and disease. Nat Rev Microbiol 22:671–686
Zmora N, Suez J, Elinav E (2019) You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol 16:35–56
doi: 10.1038/s41575-018-0061-2
pubmed: 30262901
Ashton JJ, Beattie RM (2024) Inflammatory bowel disease: recent developments. Arc Dis Child 109:370–376
doi: 10.1136/archdischild-2023-325668
Long D, Wang C, Huang Y, Mao C, Xu Y, Zhu Y (2024) Changing epidemiology of inflammatory bowel disease in children and adolescents. Int J Colorectal Dis 39:73
doi: 10.1007/s00384-024-04640-9
pubmed: 38760622
pmcid: 11101569
Wang X, Peng J, Cai P, Xia Y, Yi C, Shang A, Akanyibah FA, Mao F (2024) The emerging role of the gut microbiota and its application in inflammatory bowel disease. Biomed Pharmacother 179:117302
doi: 10.1016/j.biopha.2024.117302
pubmed: 39163678
Lacucci M, Santacroce G, Majumder S, Morael J, Zammarchi I, Maeda Y, Ryan D, Di Sabatino A, Rescigno M, Aburto MR, Cryan JF, Ghosh S (2024) Opening the doors of precision medicine: novel tools to assess intestinal barrier in inflammatory bowel disease and colitis-associated neoplasia. Gut. https://doi.org/10.1136/gutjnl-2023-331579
Farid MS, Shafique B, Xu R, Łopusiewicz Ł, Zhao C (2024) Potential interventions and interactions of bioactive polyphenols and functional polysaccharides to alleviate inflammatory bowel disease – A review. Food Chem 462:140951
doi: 10.1016/j.foodchem.2024.140951
pubmed: 39213975
Xue H, Du X, Fang S, Gao H, Xie K, Wang Y, Tan J (2024) The interaction of polyphenols-polysaccharides and their applications: a review. Int J Biol Macromol 278:134594
doi: 10.1016/j.ijbiomac.2024.134594
pubmed: 39127285
Song J, Chen Y, Lv Z, Taoerdahong H, Li G, Li J, Zhao X, Jin X, Chang J (2024) Structural characterization of a polysaccharide from Alhagi Honey and its protective effect against inflammatory bowel disease by modulating gut microbiota dysbiosis. Int J Biol Macromol 259:128937
doi: 10.1016/j.ijbiomac.2023.128937
pubmed: 38145695
Padhi S, Sarkar P, Sahoo D, Rai AK (2024) Potential of fermented foods and their metabolites in improving gut microbiota function and lowering gastrointestinal inflammation. J Sci Food Agric (in Press. https://doi.org/10.1002/jsfa.13313)
doi: 10.1002/jsfa.13313)
Cui H, Li X, Que J, Li S, Shi X, Yuan T (2024) A water-soluble arabinoxylan from Chinese liquor distillers’ grains: structural characterization and anti-colitic properties. Int J Biol Macromol 266:131186
doi: 10.1016/j.ijbiomac.2024.131186
pubmed: 38554909
Wang H, Li M, Jiao F, Ge W, Liu R, Zhi Z, Wu T, Sui W, Zhang M (2024) Soluble dietary fibers from solid-state fermentation of wheat bran by the fungus cordyceps cicadae and their effects on colitis mice. Food Funct 15:516–529
doi: 10.1039/D3FO03851C
pubmed: 38167692
Mitra D, Skidar S, Chakraborty M, Das O, Samanta A, Dutta S (2023) Gum odina prebiotic prevents experimental colitis in C57BL/6 mice model and its role in shaping gut microbial diversity. Food Biosci 53:102509
doi: 10.1016/j.fbio.2023.102509
Sinclair L, Osman OA, Bertilsson S, Eiler A (2015) Microbial community composition and diversity via 16S rRNA gene amplicons: evaluating the illumina platform. PlosOne 10:e0116955
doi: 10.1371/journal.pone.0116955
Poncheewin W, Hermes GDA, van Dam JCL, Koehorst JJ, Smidt H, Schaap PJ (2020) NG-Tax 2.0: a semantic framework for highthroughput amplicon analysis. Front Genet 10:1366
doi: 10.3389/fgene.2019.01366
pubmed: 32117417
pmcid: 6989550
Armstrong H, Mander I, Zhang Z, Armstrong D, Wine E (2021) Not all fibers are born equal; variable response to dietary fiber subtypes in IBD. Front Pediats 8:620189
doi: 10.3389/fped.2020.620189
Khan I, Bai Y, Ullah N, Liu G, Rajoka MSR, Zhang C (2022) Differential susceptibility of the gut microbiota to DSS treatment interferes in the conserved microbiome association in mouse models of colitis and is related to the initial gut microbiota difference. Adv Gut Microbiome Res 2022:7813278
Kuda T, Yokota Y, Shikano A, Takei M, Takahashi H, Kimura B (2017) Dietary and lifestyle disease indices and caecal microbiota in high fat diet, dietary fibre free diet, or DSS induced IBD models in ICR mice. J Funct Foods 35:605–914
doi: 10.1016/j.jff.2017.06.030
Zhang Y, Hu J, Zhong Y, Liu S, Liu L, Mu X, Chen C, Yang S, Li G, Zhang D, Huang X, Yang J, Huang X, Bian S, Nis S (2024) Insoluble/soluble fraction ratio determines effects of dietary fiber on gut microbiota and serum metabolites in healthy mice. Food Funct 15:338–354
doi: 10.1039/D3FO04068B
pubmed: 38088096
Fonseca-Pereira D, Bae S, Michaud M, Glickman JN, Garrett WS (2024) Chronic binge drinking-induced susceptibility to colonic inflammation is microbiome-dependent. Gut Microbes 16:2392874
doi: 10.1080/19490976.2024.2392874
pubmed: 39163515
pmcid: 11340762
Zuo W, Pang Q, Yao L, Zhang Y, Peng C, Huang W, Han B (2023) Gut microbiota: a magical multifunctional target regulated by medicine food homology species. J Adv Res 52:151–170
doi: 10.1016/j.jare.2023.05.011
pubmed: 37269937
pmcid: 10555941
Zagato E, Pozzi C, Bertocchi, Schioppa T, Saccheri F, Guglietta S et al (2020) Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth. Nat Microbiol 5:511–524
doi: 10.1038/s41564-019-0649-5
pubmed: 31988379
pmcid: 7048616
Fujita S, Lee G, Takahashi H, Nakamura A, Koga K, Handa N, Xia Y (2023) Ecklonia cava subsp. kurome and E. cava subsp. stolonifera can aid regulation of gut microbiota in mice fed a high–sucrose and low–dietary fibre diet. J Appl Phycol 35:1365–1375
doi: 10.1007/s10811-023-02966-5
Yamamoto M, Ogura H, Kuda T, Xia Y, Takahashi H, Inoue J, Takayanagi S (2023) Effects of roasted burdock root tea, drink, and the residue on caecal microbiota of mice fed low-dietary fibre diet. Food Chem Adv 3:100376
doi: 10.1016/j.focha.2023.100376
Peng L, Gao X, Nie L, Xie J, Dai T, Shi C, Tao L, Wang Y, Tian Y, Sheng J (2022) Astragalin attenuates Dextran Sulfate Sodium (DSS)-Induced acute experimental colitis by alleviating gut microbiota dysbiosis and inhibiting NF-κB activation in mice. Front Immunol 11:02058
doi: 10.3389/fimmu.2020.02058
Kim J, Lee S, Kim G, Shin HJ, Lee EJ, Lee CS, Yoon S, Lee E, Lim A, Kim SH (2024) Ameliorating effect of 2′-fucosyllactose and 6′-sialyllactose on lipopolysaccharide-induced intestinal inflammation. J Dairy Sci 107:4147–4160
doi: 10.3168/jds.2024-24325
pubmed: 38490539
Bui TPN, Troise AD, Nijsse B, Roviello GN, Fogliano V, de Vos WM (2020) Intestinimonas-like bacteria are important butyrate producers that utilize Nε-fructosyllysine and lysine in formula-fed infants and adults. J Funct Foods 70:103974
doi: 10.1016/j.jff.2020.103974
Zheng C, Zhong Y, Xie J, Wang Z, Zhang W, Pi Y, Zhang W, Liu L, Luo J, Xu W (2023) Bacteroides acidifaciens and its derived extracellular vesicles improve DSS-induced colitis. Front Microbiol 14:1304232
doi: 10.3389/fmicb.2023.1304232
pubmed: 38098663
pmcid: 10720640
Miyashita A, Xia Y, Kuda T, Yamamoto M, Nakamura A, Takahashi H (2024) Effects of Sichuan pepper (huājiāo) powder on disease activity and caecal microbiota of dextran sodium sulphate-induced inflammatory bowel disease mouse model. Mol Biol Rep 51:126
doi: 10.1007/s11033-023-09103-y
pubmed: 38236446
Constante M, Fragoso G, Calvé A, Samba-Mondonga M, Santos MM (2017) Dietary heme induces gut dysbiosis, aggravates colitis, and potentiates the development of adenomas in mice. Front Microbiol 8:01809
doi: 10.3389/fmicb.2017.01809
Abdelbary MMH, Hatting M, Bott A, Dahlhausen A, Keller D, Trautwein C, Conrads G (2022) The oral-gut axis: salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease. Front Cell Infect Microbiol 12:1010853
doi: 10.3389/fcimb.2022.1010853
pubmed: 36275026
pmcid: 9585322
Zhuang Y, Abdelsattar MM, Fu Y, Zhang N, Chai J (2024) Butyrate metabolism in rumen epithelium affected by host and diet regime through regulating microbiota in a goat model. Anim Nutr. https://doi.org/10.1016/j.aninu.2024.04.027